<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d658">
    <sentence id="DDI-DrugBank.d658.s0" text="When administered concurrently, testolactone may increase the effects of oral anticoagulants; ">
        <entity id="DDI-DrugBank.d658.s0.e0" charOffset="32-43"
            type="drug" text="testolactone"/>
        <entity id="DDI-DrugBank.d658.s0.e1" charOffset="78-91"
            type="group" text="anticoagulants"/>
        <pair id="DDI-DrugBank.d658.s0.p0" e1="DDI-DrugBank.d658.s0.e0"
            e2="DDI-DrugBank.d658.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d658.s1" text="monitor and adjust anticoagulant dosage accordingly. ">
        <entity id="DDI-DrugBank.d658.s1.e0" charOffset="19-31"
            type="group" text="anticoagulant"/>
    </sentence>
    <sentence id="DDI-DrugBank.d658.s2" text="Drug/Laboratory Test Interactions: Physiologic effects of testolactone may result in decreased estradiol concentrations with radioimmunoassays for estradiol, increased plasma calcium concentrations, and increased 24-hour urinary excretion of creatine and 17-ketosteroids.">
        <entity id="DDI-DrugBank.d658.s2.e0" charOffset="58-69"
            type="drug" text="testolactone"/>
    </sentence>
</document>
